Please login to the form below

Not currently logged in
Email:
Password:

FDA approves Teva's Alzheimer's drug

The US Food and Drug Administration has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept

The US Food and Drug Administration (FDA) has approved Teva Pharmaceutical's application to sell a generic version of Pfizer's Alzheimer's drug Aricept (donepezil).

Teva said that it has already begun shipping the product, in 5mg and 10mg tablets.

Aricept has been the market leader among drugs that alleviate symptoms of Alzheimer's disease, such as memory problems, confusion and aggression.

Annual sales of the drug in the US are believed to be $2.3 bn.

Meanwhile Teva has declined to comment on media reports that its president and chief executive Shlomo Yanai flew to India several days ago to discuss potential collaborations with Indian pharmaceutical companies.

2nd June 2011

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides powerful, insight-driven, scientific and medical communication services to the pharmaceutical industry across the globe, with...

Latest intelligence

The search for treatments for Parkinson’s disease
The research requires resilience but pharma is urged to ‘keep innovating, keep trying’...
Margot Hannah, OPEN Health - A personal perspective of LGBT+ and diversity.
Ditch the Label – it’s just me....
The impact of COVID-19 on clinical trials
As all industry sectors work to assess both the impact and the optimal path forward, the effects are expected to be diverse and long-lasting...

Infographics